Merck & Co Inc
(MEX:MRK)
MXN
2364.2
6.6 (0.28%)
Market Cap: 6.08 Til
Enterprise Value: 6.61 Til
PE Ratio: 145.24
PB Ratio: 8.20
GF Score: 75/100 - Q1 2024 Merck & Co Inc Earnings Call TranscriptApr 25, 2024MXN2227.52 (+2.53%)Earnings
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2024
- Merck & Co Inc at Leerink Partners Global Biopharma Conference TranscriptMar 11, 2024
- Merck & Co Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Merck & Co Inc Earnings Call TranscriptFeb 01, 2024MXN2140.19 (+2.86%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Merck & Co Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Merck & Co Inc at Evercore ISI HealthCONx Conference TranscriptNov 30, 2023
- Merck & Co Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2023
- Merck & Co Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Merck & Co Inc Earnings Call TranscriptOct 26, 2023MXN1900.71Earnings
- Merck & Co Inc To Host ESMO Call (Virtual) TranscriptOct 22, 2023
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Merck & Co Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Merck & Co Inc Earnings Call TranscriptAug 01, 2023MXN1788 (+0.12%)Earnings
- Merck & Co Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Merck & Co Inc Investor Event at ASCO 2023 TranscriptJun 05, 2023
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 23, 2023
- Merck & Co Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Merck & Co Inc Earnings Call TranscriptApr 27, 2023MXN2057.66Earnings
- Merck & Co Inc Acquisition of Prometheus Biosciences- M&A Call TranscriptApr 17, 2023
- Merck & Co Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Merck & Co Inc Investor Event at ACC.23/WCC TranscriptMar 07, 2023
- Q4 2022 Merck & Co Inc Earnings Call TranscriptFeb 02, 2023MXN1922.55 (-3.50%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Merck & Co Inc at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Merck & Co Inc Earnings Call TranscriptOct 27, 2022MXN1976.32 (+0.84%)Earnings
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Merck & Co Inc Earnings Call TranscriptJul 28, 2022MXN1848 (-0.65%)Earnings
- Merck & Co Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Merck & Co Inc at ASCO Annual Meeting TranscriptJun 07, 2022
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 24, 2022
- Merck & Co Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Merck & Co Inc Earnings Call TranscriptApr 28, 2022MXN1794.01 (+3.52%)Earnings
- Merck & Co Inc Cardiovascular Event TranscriptApr 05, 2022
- Merck & Co Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Merck & Co Inc ESG Investor Event TranscriptFeb 23, 2022
- Merck & Co Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Merck & Co Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 09, 2022
- Q4 2021 Merck & Co Inc Earnings Call TranscriptFeb 03, 2022MXN1632 (-3.41%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Merck & Co Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Merck & Co Inc Earnings Call TranscriptOct 28, 2021MXN1763.67 (+6.50%)Earnings
- Acceleron Pharma Inc Acquired by Merck & Co Inc Call TranscriptSep 30, 2021
- Merck & Co Inc Oncology Event at ESMO 2021 TranscriptSep 20, 2021
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Merck & Co Inc Earnings Call TranscriptJul 29, 2021MXN1527.01 (-2.37%)Earnings
- Merck & Co Inc at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 22, 2021
- Merck & Co Inc Oncology Event at ASCO TranscriptJun 07, 2021
- Merck & Co Inc at CECP CEO Investor Forum (Virtual) TranscriptJun 07, 2021
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Merck & Co Inc Investor Day (Virtual) TranscriptMay 03, 2021
- Q1 2021 Merck & Co Inc Earnings Call TranscriptApr 29, 2021MXN1404.95 (-3.88%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Merck & Co Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Merck & Co Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Merck & Co Inc Earnings Call TranscriptFeb 04, 2021MXN1485.09 (-0.79%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck & Co Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Q3 2020 Merck & Co Inc Earnings Call TranscriptOct 27, 2020MXN1572.29 (-0.49%)Earnings
- Merck & Co Inc Oncology Virtual IR Briefing -- ESMO 2020 TranscriptSep 22, 2020
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- Merck & Co Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Seattle Genetics Inc Discussion of Oncology Collaborations with Merck & Co Inc - Conference Call TranscriptSep 14, 2020
- Merck & Co Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Merck & Co Inc Earnings Call TranscriptJul 31, 2020MXN1698.15 (+1.83%)Earnings
- Merck & Co Inc Oncology Event at ASCO 2020 TranscriptJun 02, 2020
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 26, 2020
- Merck & Co Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Merck & Co Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Merck & Co Inc Earnings Call TranscriptApr 28, 2020MXN1887.89 (-5.35%)Earnings
- Merck & Co Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Merck & Co Inc Earnings Call TranscriptFeb 05, 2020MXN1516.14 (-3.92%)Earnings
- Merck & Co Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Merck & Co Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Q3 2019 Merck & Co Inc Earnings Call TranscriptOct 29, 2019MXN1567.51 (+4.95%)Earnings
- Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Merck & Co Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Merck & Co Inc Earnings Call TranscriptJul 30, 2019MXN1513.65 (+2.39%)Earnings
- Merck & Co Inc Investor Day TranscriptJun 20, 2019
- Merck & Co Inc Annual Shareholders Meeting TranscriptMay 28, 2019
- Q1 2019 Merck & Co Inc Earnings Call TranscriptApr 30, 2019MXN1421.64 (+2.76%)Earnings
- Q4 2018 Merck & Co Inc Earnings Call TranscriptFeb 01, 2019MXN1407.33 (+4.81%)Earnings
Merck & Co Inc at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022 / 09:20PM GMT
Release Date Price:
MXN1550.01
(-0.98%)
Daina Michelle Graybosch
SVB Leerink LLC, Research Division - MD of Immuno-Oncology & Senior Research Analyst
Hello, everyone. Welcome to our session this afternoon with Merck. I am really pleased to host Caroline Litchfield and Peter Dannenbaum.
And if you don't know me, I am the immuno-oncology analyst here at SVB Leerink. You may say, "Well, why do you cover Merck?" And it is because immuno-oncology is important to Merck. And actually, I love it because I love thinking about things other than immuno-oncology as well. And so always happy to talk with Merck management and really excited to have you both with us today.
Caroline Litchfield
Merck & Co., Inc. - Executive VP & CFO
Thank you, Daina.
Daina Michelle Graybosch
SVB Leerink LLC, Research Division - MD of Immuno-Oncology & Senior Research Analyst
And one point of process for people listening, if you'd like me to pose a question to Caroline or Peter, please look at the box below my finger, put it there. If you e-mail it to me, I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)